Business Description
Compare
Compare
Traded in other countries / regions
XBIO.Thailand IPO Date
2003-12-22Description
X Bioscience PCL, along with its subsidiaries, is mainly engaged in selling food and beverages by operating restaurants and bakery shops under the Le Boeuf, Kagonoya, Bake Cheese Tart, Croquant Chou ZakuZaku, and RAPL trademarks. Additionally, the Group is involved in the production and distribution of biological products. It operates in two business segments: the food and beverage sales segment, which generates maximum revenue, and the production and distribution of biological products segment. Geographically, the Group operates only in Thailand.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.15 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.55 | |||||
Debt-to-EBITDA | -0.26 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -6.21 | |||||
Beneish M-Score | -1.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -36.5 | |||||
3-Year EBITDA Growth Rate | -25.7 | |||||
3-Year EPS without NRI Growth Rate | 1.7 | |||||
3-Year FCF Growth Rate | 43 | |||||
3-Year Book Growth Rate | -18.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.02 | |||||
9-Day RSI | 41.97 | |||||
14-Day RSI | 44.4 | |||||
6-1 Month Momentum % | 50 | |||||
12-1 Month Momentum % | -83.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.97 | |||||
Quick Ratio | 0.97 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 17.01 | |||||
Days Sales Outstanding | 31.04 | |||||
Days Payable | 486.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -57.7 | |||||
Shareholder Yield % | -39.74 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 40.31 | |||||
Operating Margin % | -267.67 | |||||
Net Margin % | -441.88 | |||||
EBITDA Margin % | -438.7 | |||||
FCF Margin % | -72.84 | |||||
OCF Margin % | -67.37 | |||||
ROE % | -201.5 | |||||
ROA % | -80.39 | |||||
ROIC % | -52.18 | |||||
3-Year ROIIC % | 34.02 | |||||
ROC (Joel Greenblatt) % | -194.73 | |||||
ROCE % | -145.69 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.17 | |||||
PB Ratio | 2.59 | |||||
Price-to-Tangible-Book | 2.33 | |||||
EV-to-EBIT | -1.4 | |||||
EV-to-EBITDA | -1.44 | |||||
EV-to-Revenue | 6.33 | |||||
EV-to-FCF | -8.69 | |||||
Price-to-GF-Value | 0.7 | |||||
Price-to-Median-PS-Value | 0.64 | |||||
Earnings Yield (Greenblatt) % | -71.43 | |||||
FCF Yield % | -13.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
X Bioscience PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 159.287 | ||
| EPS (TTM) (฿) | -0.27 | ||
| Beta | 0.6441 | ||
| 3-Year Sharpe Ratio | -0.3 | ||
| 3-Year Sortino Ratio | -0.42 | ||
| Volatility % | 144.84 | ||
| 14-Day RSI | 44.4 | ||
| 14-Day ATR (฿) | 0.009799 | ||
| 20-Day SMA (฿) | 0.0775 | ||
| 12-1 Month Momentum % | -83.44 | ||
| 52-Week Range (฿) | 0.026612 - 0.696292 | ||
| Shares Outstanding (Mil) | 12,163.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
X Bioscience PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
X Bioscience PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| 0.142857:1 Stock Split | 2025-10-03 | 0.54 (+6.67%) | ||
| 0.066667:1 Stock Split | 2021-07-01 | 83.98 (+0.58%) | ||
| 0.066667:1 Stock Split | 2021-05-05 | 87.38 (+0.00%) | ||
| 5:1 Stock Split | 2007-05-21 | 550.02 (-0.64%) |
Show
Entries
X Bioscience PCL Frequently Asked Questions
What is X Bioscience PCL(BKK:XBIO)'s stock price today?
The current price of BKK:XBIO is ฿0.07. The 52 week high of BKK:XBIO is ฿0.70 and 52 week low is ฿0.03.
When is next earnings date of X Bioscience PCL(BKK:XBIO)?
The next earnings date of X Bioscience PCL(BKK:XBIO) is .
Does X Bioscience PCL(BKK:XBIO) pay dividends? If so, how much?
X Bioscience PCL(BKK:XBIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on X Bioscience PCL
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers